Impact Partnership Wealth LLC Buys Shares of 1,695 UnitedHealth Group Incorporated (NYSE:UNH)

Impact Partnership Wealth LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,695 shares of the healthcare conglomerate’s stock, valued at approximately $888,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Brogan Financial Inc. increased its holdings in shares of UnitedHealth Group by 3.4% during the 1st quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock worth $429,000 after acquiring an additional 27 shares during the last quarter. Resurgent Financial Advisors LLC lifted its position in shares of UnitedHealth Group by 3.1% during the 1st quarter. Resurgent Financial Advisors LLC now owns 1,345 shares of the healthcare conglomerate’s stock valued at $704,000 after acquiring an additional 41 shares during the period. Keyes Stange & Wooten Wealth Management LLC lifted its position in shares of UnitedHealth Group by 20.7% during the 1st quarter. Keyes Stange & Wooten Wealth Management LLC now owns 786 shares of the healthcare conglomerate’s stock valued at $412,000 after acquiring an additional 135 shares during the period. Balentine LLC lifted its position in shares of UnitedHealth Group by 8.8% during the 1st quarter. Balentine LLC now owns 842 shares of the healthcare conglomerate’s stock worth $441,000 after buying an additional 68 shares during the last quarter. Finally, Buckhead Capital Management LLC lifted its position in shares of UnitedHealth Group by 2.6% during the 1st quarter. Buckhead Capital Management LLC now owns 14,668 shares of the healthcare conglomerate’s stock worth $7,682,000 after buying an additional 372 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on UNH shares. Barclays reissued an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday. Oppenheimer lowered their price objective on UnitedHealth Group from $600.00 to $400.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. Piper Sandler lowered their price objective on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating for the company in a research report on Tuesday, June 3rd. Argus downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Finally, Royal Bank Of Canada lowered their price objective on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research report on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $394.43.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, CEO Stephen J. Hemsley bought 86,700 shares of the business’s stock in a transaction on Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer owned 679,493 shares in the company, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have purchased 109,408 shares of company stock worth $31,607,768 over the last quarter. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Price Performance

UNH opened at $282.45 on Friday. The stock has a 50-day moving average price of $304.47 and a 200-day moving average price of $433.39. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $256.22 billion, a P/E ratio of 11.83, a PEG ratio of 1.41 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the prior year, the company earned $6.91 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 3.13%. The ex-dividend date was Monday, June 16th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio (DPR) is 37.02%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.